PMID- 18520330 OWN - NLM STAT- MEDLINE DCOM- 20080626 LR - 20211020 IS - 0031-3998 (Print) IS - 1530-0447 (Electronic) IS - 0031-3998 (Linking) VI - 63 IP - 6 DP - 2008 Jun TI - Diffuse axonal injury in periventricular leukomalacia as determined by apoptotic marker fractin. PG - 656-61 LID - 10.1203/PDR.0b013e31816c825c [doi] AB - Periventricular leukomalacia (PVL), the major substrate of neurologic deficits in premature infants, is associated with reduced white matter volume. Using immunomarkers of axonal pathology [beta-amyloid precursor protein (beta-APP) and apoptotic marker fractin], we tested the hypothesis that widespread (diffuse) axonal injury occurs in the gliotic white matter beyond the foci of necrosis in PVL, thus contributing to the white matter volume reduction. In a cohort of 17 control cases and 13 PVL cases with lesions of different chronological ages, diffuse axonal damage in PVL was detected by fractin in white matter sites surrounding and distant from acute and organizing foci of necrosis. Using beta-APP, axonal spheroids were detected within necrotic foci in the acute and organizing (subacute) stages, a finding consistent with others. Interestingly, GAP-43 expression was also detected in spheroids in the necrotic foci, suggesting attempts at axonal regeneration. Thirty-one percent of the PVL cases had thalamic damage and 15% neuronal injury in the cerebral cortex overlying PVL. We conclude that diffuse axonal injury, as determined by apoptotic marker fractin, occurs in PVL and that its cause likely includes primary ischemia and trophic degeneration secondary to corticothalamic neuronal damage. FAU - Haynes, Robin L AU - Haynes RL AD - Department of Pathology, Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. robin.haynes@childrens.harvard.edu FAU - Billiards, Saraid S AU - Billiards SS FAU - Borenstein, Natalia S AU - Borenstein NS FAU - Volpe, Joseph J AU - Volpe JJ FAU - Kinney, Hannah C AU - Kinney HC LA - eng GR - P01 NS038475/NS/NINDS NIH HHS/United States GR - P01 NS038475-09/NS/NINDS NIH HHS/United States GR - P30-HD18655/HD/NICHD NIH HHS/United States GR - P30 HD018655/HD/NICHD NIH HHS/United States GR - P01-NS38475/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - United States TA - Pediatr Res JT - Pediatric research JID - 0100714 RN - 0 (Actins) RN - 0 (Amyloid beta-Protein Precursor) RN - 0 (GAP-43 Protein) SB - IM MH - Actins/*analysis MH - Amyloid beta-Protein Precursor/analysis MH - *Apoptosis MH - Autopsy MH - Axons/chemistry/*pathology MH - Case-Control Studies MH - Cerebral Cortex/chemistry/pathology MH - Cerebrum/chemistry/*pathology MH - Diffuse Axonal Injury/*etiology/metabolism/pathology MH - GAP-43 Protein/analysis MH - Humans MH - Infant MH - Infant, Newborn MH - Leukomalacia, Periventricular/*complications/metabolism/pathology MH - Necrosis MH - Thalamus/chemistry/pathology PMC - PMC2770332 MID - NIHMS112447 EDAT- 2008/06/04 09:00 MHDA- 2008/06/27 09:00 PMCR- 2009/10/29 CRDT- 2008/06/04 09:00 PHST- 2008/06/04 09:00 [pubmed] PHST- 2008/06/27 09:00 [medline] PHST- 2008/06/04 09:00 [entrez] PHST- 2009/10/29 00:00 [pmc-release] AID - 00006450-200806000-00012 [pii] AID - 10.1203/PDR.0b013e31816c825c [doi] PST - ppublish SO - Pediatr Res. 2008 Jun;63(6):656-61. doi: 10.1203/PDR.0b013e31816c825c.